Regulatory biostatistics is the discipline of designing trial statistics and writing the statistical sections of submissions so they satisfy regulators — CDSCO in India, FDA, EMA — covering things like pre-specified analysis plans, multiplicity control, and interim-analysis rules. It's core to the Biostatistician role at CROs and pharma companies running India-based or global trials, since a statistically weak submission can delay or sink a drug approval. This knowledge is built through graduate biostatistics training plus real submission experience, and it's among the most senior, highest-paid tracks within clinical biostatistics.
The skills most often needed alongside Regulatory Biostatistics in the same roles — build these together to widen your options.
Three trait assessments. Six dimensions. 869 careers, scored against the way you actually work. ₹149 for a year. ₹0 to try.